• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    34.36 Up 0.13(0.38%) Jul 31, 4:00PM EDT
    Add to Portfolio
    Prev Close:34.23
    Open:34.75
    Bid:33.55 x 1000
    Ask:42.00 x 200
    1y Target Est:44.00
    Beta:0.92
    Earnings Date:Oct 28 - Nov 2 (Est.)
    Day's Range:33.47 - 34.75
    52wk Range:28.52 - 45.45
    Volume:488,739
    Avg Vol (3m):567,220
    Market Cap:1.47B
    P/E (ttm):103.81
    EPS (ttm):0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACOR

    Comparison

    Symbol% ChgMkt Cap
    ACORUp 0.38%1.47B
    BIIBUp 0.56%74.97B
    TEVADown 0.07%58.53B

    Key Statistics

    Forward P/E (1 yr):38.61
    P/S (ttm):3.48
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.58
    Quarterly EPS Est (Sep-15) :0.13
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):1.60

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback